WO2024241248 - COMPOUNDS TARGETING KRAS G12D MUTATIONS AND THEIR USES
National phase entry is expected:
Publication Number
WO/2024/241248
Publication Date
28.11.2024
International Application No.
PCT/IB2024/054989
International Filing Date
22.05.2024
Title **
[English]
COMPOUNDS TARGETING KRAS G12D MUTATIONS AND THEIR USES
[French]
COMPOSÉS CIBLANT DES MUTATIONS DE KRAS G12D ET LEURS UTILISATIONS
Applicants **
INNOPHARMASCREEN INC.
28 FL, V689, 165, Convensia-daero
Yeonsu-gu
Incheon 21988, KR
Inventors
KANG, Incheol
602-1204, 96, Convensia-daero 42 beon-gil,
Yeonsu-gu
Incheon 22001, KR
SEO, Seung O
2-402, 9, Songdomirae-ro,
Yeonsu-gu
Incheon 21988, KR
Priority Data
10-2023-0065774
22.05.2023
KR
Application details
Total Number of Claims/PCT | * |
Number of Independent Claims | * |
Number of Priorities | * |
Number of Multi-Dependent Claims | * |
Number of Drawings | * |
Pages for Publication | * |
Number of Pages with Drawings | * |
Pages of Specification | * |
* | |
* | |
International Searching Authority |
KIPO
* |
Applicant's Legal Status |
Legal Entity
* |
* | |
* | |
* | |
* | |
Entry into National Phase under |
Chapter I
* |
Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
Country | Stages | Total | |
---|---|---|---|
China | Filing | 1288 | |
EPO | Filing, Examination | 7340 | |
Japan | Filing | 551 | |
South Korea | Filing | 577 | |
USA | Filing, Examination | 5035 |


Total: 14791 USD
Abstract[English]
The present disclosure relates to compounds targeting KRAS G12D and G12V mutations and uses thereof.[French]
La présente invention concerne des composés ciblant des mutations de KRAS G12D et G12V et leurs utilisations.